Sign in to view content

Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2018

Related

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Multilayered Inverse Internal Limiting Membrane Peeling – Is ILM the Culprit or Savior in the Treatment of Large Macular Holes and Macular Hole R.D.?
Srinivas Joshi, MD, FASRS
Annual Meeting Talks
2018
Earliest Diabetic Retinopathy Detection Using Optical Coherence Tomography Angiography (OCTA) Perfused Capillary Density
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more